Functional Adhesiveness of the CX3CL1 Chemokine Requires Its Aggregation ROLE OF THE TRANSMEMBRANE DOMAIN

被引:40
|
作者
Hermand, Patricia [2 ]
Pincet, Frederic [3 ]
Carvalho, Stephanie [2 ]
Ansanay, Herve [4 ]
Trinquet, Eric [4 ]
Daoudi, Mehdi [2 ]
Combadiere, Christophe [2 ,5 ]
Deterre, Philippe [1 ,2 ]
机构
[1] Univ Paris 06, Fac Med Pitie Salpetriere, Lab Immunol Cellulaire, INSERM,U543, F-75013 Paris, France
[2] Univ Paris 06, Lab Immunol Cellulaire, INSERM UMR S 543, F-75013 Paris, France
[3] Ecole Normale Super, Lab Phys Stat, UMR CNRS 8550, F-75231 Paris, France
[4] Cisbio Int, HTRF Res, F-30204 Bagnols Sur Ceze, France
[5] AP HP, Lab Immunol Cellulaire & Tissulaire, F-75013 Paris, France
关键词
D O I
10.1074/jbc.M802638200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In its native form, the chemokine CX3CL1 is a firmly adhesive molecule promoting leukocyte adhesion and migration and hence involved, along with its unique receptor CX3CR1, in various inflammatory processes. Here we investigated the role of molecular aggregation in the CX3CL1 adhesiveness. Assays of bioluminescence resonance energy transfer (BRET) and homogeneous time-resolved fluorescence (HTRF) in transfected cell lines and in primary cells showed specific signals indicative of CX3CL1 clustering. Truncation experiments showed that the transmembrane domain played a central role in this aggregation. A chimera with mutations of the 12 central transmembrane domain residues had significantly reduced BRET signals and characteristics of a non-clustering molecule. This mutant was weakly adhesive according to flow and dual pipette adhesion assays and was less glycosylated than CX3CL1, although, as we demonstrated, loss of glycosylation did not affect the CX3CL1 adhesive potency. We postulate that cell surfaces express CX3CL1 as a constitutive oligomer and that this oligomerization is essential for its adhesive potency. Inhibition of CX3CL1 self-assembly could limit the recruitment of CX3CR1-positive cells and may be a new pathway for anti-inflammatory therapies.
引用
收藏
页码:30225 / 30234
页数:10
相关论文
共 50 条
  • [1] Requirements for leukocyte transmigration via the transmembrane chemokine CX3CL1
    Schwarz, Nicole
    Pruessmeyer, Jessica
    Hess, Franz M.
    Dreymueller, Daniela
    Pantaler, Elena
    Koelsch, Anne
    Windoffer, Reinhard
    Voss, Matthias
    Sarabi, Alisina
    Weber, Christian
    Sechi, Antonio S.
    Uhlig, Stefan
    Ludwig, Andreas
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2010, 67 (24) : 4233 - 4248
  • [2] Requirements for leukocyte transmigration via the transmembrane chemokine CX3CL1
    Nicole Schwarz
    Jessica Pruessmeyer
    Franz M. Hess
    Daniela Dreymueller
    Elena Pantaler
    Anne Koelsch
    Reinhard Windoffer
    Matthias Voss
    Alisina Sarabi
    Christian Weber
    Antonio S. Sechi
    Stefan Uhlig
    Andreas Ludwig
    Cellular and Molecular Life Sciences, 2010, 67 : 4233 - 4248
  • [3] Proteolytic shedding of the transmembrane chemokine CX3CL1 involves multiple structural determinants
    Andrzejewski, M. G.
    Hess, F. M.
    Ludwig, A.
    WIENER KLINISCHE WOCHENSCHRIFT, 2008, 120 : 181 - 182
  • [4] The Chemokine CX3CL1 (Fractalkine) and its Receptor CX3CR1: Occurrence and Potential Role in Osteoarthritis
    Wojdasiewicz, Piotr
    Poniatowski, Lukasz A.
    Kotela, Andrzej
    Deszczynski, Jaroslaw
    Kotela, Ireneusz
    Szukiewicz, Dariusz
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2014, 62 (05) : 395 - 403
  • [5] EVALUATION OF THE ROLE OF FRACTALKINE CHEMOKINE CX3CL1 AND ITS RECEPTOR CX3CR1 IN INFLAMMATORY MYOPATHIES
    Colafrancesco, S.
    Priori, R.
    Astorri, E.
    Scrivo, R.
    D'Amati, G.
    Giordano, C.
    Valesini, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 568 - 568
  • [6] The Chemokine CX3CL1 (Fractalkine) and its Receptor CX3CR1: Occurrence and Potential Role in Osteoarthritis
    Piotr Wojdasiewicz
    Łukasz A. Poniatowski
    Andrzej Kotela
    Jarosław Deszczyński
    Ireneusz Kotela
    Dariusz Szukiewicz
    Archivum Immunologiae et Therapiae Experimentalis, 2014, 62 : 395 - 403
  • [7] An overview of the role of chemokine CX3CL1 (Fractalkine) and CX3C chemokine receptor 1 in systemic sclerosis
    Pezeshkian, Fatemehsadat
    Shahriarirad, Reza
    Mahram, Hadiseh
    IMMUNITY INFLAMMATION AND DISEASE, 2024, 12 (10)
  • [8] Role of CX3CL1 in Diseases
    WangMi Liu
    Libo Jiang
    Chong Bian
    Yun Liang
    Rong Xing
    Mumingjiang Yishakea
    Jian Dong
    Archivum Immunologiae et Therapiae Experimentalis, 2016, 64 : 371 - 383
  • [9] The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo
    Lucas, AD
    Chadwick, N
    Warren, BF
    Jewell, DP
    Gordon, S
    Powrie, F
    Greaves, DR
    AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (03): : 855 - 866
  • [10] Role of CX3CL1 in Diseases
    Liu, WangMi
    Jiang, Libo
    Bian, Chong
    Liang, Yun
    Xing, Rong
    Yishakea, Mumingjiang
    Dong, Jian
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2016, 64 (05) : 371 - 383